Collaborations Pharmaceuticals Inc.
Collaborations Pharmaceuticals develops drugs for rare and neglected diseases using machine learning software, providing preclinical and clinical expertise to rare disease foundations, academic scientists and companies developing clinical candidates. Collaborations also provides machine learning expertise and software to consumer product and agrochemical companies.
Employment range in NC
Primary site activity
All company activities
Potential end market(s)
Products on market
Machine learning model collections - Assay Central, MegaTox, MegaPredict, MegaTrans, UV-adVISor. Generative design software: MegaSyn.
Products under development
Treatments for Ebola, Marburg, Nipah, Acute Flaccid myelitis, Alzheimer's disease, Chagas disease, Pitt Hopkins Syndrome, COVID-19, Batten disease, tuberculosis, HIV, rare cancers